Angiogenic profiling in patients with advanced well-differentiated pancreatic neuroendocrine tumors treated with everolimus

被引：0
|
作者：
Cella, C. A. [1 ]
Spada, F. [1 ]
Galdy, S. [1 ]
Frezza, A. M. [1 ]
Catapano, M. [1 ]
Funicelli, L. [1 ]
Calleri, A. [1 ]
Zorzino, L. [1 ]
Mancuso, P. [1 ]
Radice, D. [1 ]
Fazio, N. [1 ]
机构：
[1] European Inst Oncol, Gastrintestinal Tumors & Neuroendocrine Tumors Un, Milan, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)31260-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2344
引用
收藏
页码：S449 / S449
页数：1
相关论文
共 50 条
  • [1] Diffusion-MRI and angiogenic profiling in patients with advanced well-differentiated pancreatic neuroendocrine tumors treated with everolimus
    Cella, C. A.
    Spada, F.
    Galdy, S.
    Frezza, A. M.
    Catapano, M.
    Funicelli, L.
    Mancuso, P.
    Zorzino, L.
    Radice, D.
    Calleri, A.
    Fazio, N.
    ANNALS OF ONCOLOGY, 2015, 26 : 144 - 144
  • [2] A phase II study of Lenvatinib and Everolimus in advanced well-differentiated extra pancreatic neuroendocrine tumors
    Dasari, A.
    Qiao, W.
    Halperin, D.
    Stanietzky, N.
    Surabhi, V
    Phillips, M.
    Sakamuri, D.
    Wilson, K.
    Leung, M.
    Smack, M.
    Yao, J.
    JOURNAL OF NEUROENDOCRINOLOGY, 2024, 36 : 232 - 232
  • [3] Angiogenic Circulating Biomarkers in Patients with Advanced Pancreatic Neuroendocrine Tumors Treated with Everolimus
    Cella, C. A.
    Spada, F.
    Labanca, V
    Radice, D.
    Rubino, M.
    Zorzino, L.
    Fazio, N.
    NEUROENDOCRINOLOGY, 2017, 105 : 3 - 3
  • [4] The Efficacy and Safety of Sunitinib in Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (12) : 10 - 11
  • [5] The Efficacy and Safety of Sunitinib in Patients With Advanced Well-differentiated Pancreatic Neuroendocrine Tumors
    Raymond, Eric
    Kulke, Matthew
    Qin, Shukui
    Schenker, Michael
    Cubillo, Antonio
    Lou, Wenhui
    Tomasek, Jiri
    Thiis-Evensen, Espen
    Xu, Jianming
    Racz, Karoly
    Croitoru, Adina
    Khasraw, Mustafa
    Sedlackova, Eva
    Borbath, Ivan
    Ruff, Paul
    Oberstein, Paul
    Ito, Tetsuhide
    Fernandez, Kathrine
    Rosbrook, Brad
    Fazio, Nicola
    PANCREAS, 2017, 46 (03) : 435 - 435
  • [6] Ribociclib and everolimus in well-differentiated foregut neuroendocrine tumors
    Raj, Nitya
    Zheng, Youyun
    Hauser, Haley
    Chou, Joanne
    Rafailov, Johnathan
    Bou-Ayache, Jad
    Sawan, Peter
    Chaft, Jamie
    Chan, Jennifer
    Perez, Kimberly
    Rudin, Charles
    Tang, Laura
    Reidy-Lagunes, Diane
    ENDOCRINE-RELATED CANCER, 2021, 28 (04) : 237 - 246
  • [7] The efficacy and safety of sunitinib in patients with advanced well-differentiated pancreatic neuroendocrine tumors.
    Raymond, Eric
    Kulke, Matthew H.
    Qin, Shukui
    Schenker, Michael
    Cubillo, Antonio
    Lou, Wenhui
    Tomasek, Jiri
    Thiis-Evensen, Espen
    Xu, Jianming
    Racz, Karoly
    Croitoru, Adina E.
    Khasraw, Mustafa
    Sedlackova, Eva
    Borbath, Ivan
    Ruff, Paul
    Oberstein, Paul Eliezer
    Ito, Tetsuhide
    Fernandez, Kathrine C.
    Rosbrook, Brad
    Fazio, Nicola
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [8] RESPONSE EVALUATION USING RECIST AND CHOI CRITERIA IN PATIENTS WITH WELL-DIFFERENTIATED PANCREATIC NEUROENDOCRINE TUMORS (PNET) TREATED WITH SUNITINIB OR EVEROLIMUS
    Dreyer, C.
    Hentic, O.
    Zappa, M.
    Hammel, P.
    Bouattour, M.
    Mateescu, C.
    Faivre, S.
    Ruszniewski, P.
    Raymond, E.
    ANNALS OF ONCOLOGY, 2012, 23 : 379 - 379
  • [9] Treatment of advanced disease in patients with well-differentiated neuroendocrine tumors
    Diane L Reidy
    Laura H Tang
    Leonard B Saltz
    Nature Reviews Clinical Oncology, 2009, 6 : 143 - 152
  • [10] Response evaluation using RECIST and CHOI criteria in patients with well-differentiated pancreatic neuroendocrine tumors (pNET) treated with sunitinib or everolimus
    Hentic, Olivia
    Dreyer, Chantal
    Zappa, Magaly
    Hammel, Pascal
    Mateescu, Cristian
    Bouattour, Mohamed
    Faivre, Sandrine J.
    Ruszniewski, Philippe
    Raymond, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345